Towards protein-based viral mimetics for cancer therapies
High resistance and recurrence rates, together with elevated drug clearance, compel the
use of maximum-tolerated drug doses in cancer therapy, resulting in high-grade toxicities …
use of maximum-tolerated drug doses in cancer therapy, resulting in high-grade toxicities …
Exploitation of viral properties for intracellular delivery
S Galdiero, A Falanga, M Vitiello… - Journal of Peptide …, 2014 - Wiley Online Library
Nanotechnology is an expanding area of study with potentially pivotal applications in a
discipline as medicine where new biomedical active molecules or strategies are …
discipline as medicine where new biomedical active molecules or strategies are …
Using viruses as nanomedicines
HE van Kan‐Davelaar, JCM Van Hest… - British journal of …, 2014 - Wiley Online Library
The field of nanomedicine involves the design and fabrication of novel nanocarriers for the
intracellular delivery of therapeutic cargo or for use in molecular diagnostics. Although …
intracellular delivery of therapeutic cargo or for use in molecular diagnostics. Although …
Delivery of cancer therapies by synthetic and bio-inspired nanovectors
T Briolay, T Petithomme, M Fouet, N Nguyen-Pham… - Molecular cancer, 2021 - Springer
Background As a complement to the clinical development of new anticancer molecules,
innovations in therapeutic vectorization aim at solving issues related to tumor specificity and …
innovations in therapeutic vectorization aim at solving issues related to tumor specificity and …
Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy
DM Dogbey, VES Torres, E Fajemisin… - Drug Delivery and …, 2023 - Springer
The burden of cancer is increasing globally. Several challenges facing its mainstream
treatment approaches have formed the basis for the development of targeted delivery …
treatment approaches have formed the basis for the development of targeted delivery …
Virus-based nanocarriers for drug delivery
Y Ma, RJM Nolte, JJLM Cornelissen - Advanced drug delivery reviews, 2012 - Elsevier
New nanocarrier platforms based on natural biological building blocks offer great promises
in revolutionalizing medicine. The usage of specific protein cage structures: virus-like …
in revolutionalizing medicine. The usage of specific protein cage structures: virus-like …
Systematic Engineering of Uniform, Highly Efficient, Targeted and Shielded Viral‐Mimetic Nanoparticles
In the past decades, numerous types of nanomedicines have been developed for the
efficient and safe delivery of nucleic acid‐based drugs for cancer therapy. Given that the …
efficient and safe delivery of nucleic acid‐based drugs for cancer therapy. Given that the …
Tailored functionalized protein nanocarriers for cancer therapy: recent developments and prospects
MAA Abdelhamid, MR Ki, AAA El-Hafeez, RG Son… - Pharmaceutics, 2023 - mdpi.com
Recently, the potential use of nanoparticles for the targeted delivery of therapeutic and
diagnostic agents has garnered increased interest. Several nanoparticle drug delivery …
diagnostic agents has garnered increased interest. Several nanoparticle drug delivery …
Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force
Z Wang, K Zhi, Z Ding, Y Sun, S Li, M Li, K Pu… - Seminars in cancer …, 2021 - Elsevier
Cancer has thwarted as a major health problem affecting the global population. With an
alarming increase in the patient population suffering from diverse varieties of cancers, the …
alarming increase in the patient population suffering from diverse varieties of cancers, the …
Protein nanocarriers for targeted drug delivery for cancer therapy
MY Kariduraganavar, GB Heggannavar… - Nanocarriers for drug …, 2019 - Elsevier
This chapter describes how proteins can be used to provide effective targeted nanocarriers
for drugs to target tumors. This approach offers an exciting framework for cancer therapies in …
for drugs to target tumors. This approach offers an exciting framework for cancer therapies in …